SHELLY BISHARD: Open Payments
NPI 1750900130 · LEWISVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,895 in 278 payments from 19 companies in 2025. Trend: 2023 $2,683 · 2024 $4,252 · 2025 $3,895
Food & beverage: $3,778Education: $117
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 45 | $780 |
| Lundbeck LLC | 34 | $463 |
| Otsuka America Pharmaceutical, Inc. | 44 | $429 |
| ABBVIE INC. | 23 | $354 |
| Neurocrine BioSciences, Inc. | 23 | $344 |
| Alkermes, Inc. | 8 | $229 |
| Supernus Pharmaceuticals, Inc. | 24 | $217 |
| E.R. Squibb & Sons, L.L.C. | 21 | $217 |
| Collegium Pharmaceutical, Inc. | 16 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $157 |
Products named: REXULTI, UZEDY, VRAYLAR, INGREZZA, AUSTEDO XR, COBENFY, Qelbree, Jornay PM.
Industry payments across TX — which companies pay providers there.
